High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$3.0M
$2,999,999
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
IKT
P
Inhibikase Therapeutics, Inc.
Sands Capital Life Sciences Pulse Fund II, L.P.
• 10% Owner
Discretionary BuyΔOwn +18.9%
2025-11-21
$2,999,999Large
|
||||||
| IKT |
Inhibikase Therapeutics, Inc.
|
10% Owner
Discretionary BuyΔOwn +18.9%
|
2025-11-21 | $2,999,999Large | P | Form 4 |